We first evaluated miR-155 expression in primary CD138+ cells from 4 normal donors and 95 MM patients by analyzing the purified bone marrow CD138+ cell fraction of all patients included in a proprietary microarray dataset available through GEO accession number GSE87830 (Figure 1). This evidence concerns the gene SDC1 and Miyoshi myopathy.